Abstract

Understanding the epigenetic control of normal differentiation programs might yield principal information about critical regulatory states that are disturbed in cancer. We utilized the established non-malignant HPr1-AR prostate epithelial cell model that upon androgen exposure commits to a luminal cell differentiation trajectory from that of a basal-like state. We profile the dynamic transcriptome associated with this transition at multiple time points (0 h, 1 h, 24 h, 96 h), and confirm that expression patterns are strongly indicative of a progressive basal to luminal cell differentiation program based on human expression signatures. Furthermore, we establish dynamic patterns of DNA methylation associated with this program by use of whole genome bisulfite sequencing (WGBS). Expression patterns associated with androgen induced luminal cell differentiation were found to have significantly elevated DNA methylation dynamics. Shifts in methylation profiles were strongly associated with Polycomb repressed regions and to promoters associated with bivalency, and strongly enriched for binding motifs of AR and MYC. Importantly, we found that dynamic DNA methylation patterns observed in the normal luminal cell differentiation program were significant targets of aberrant methylation in prostate cancer. These findings suggest that the normal dynamics of DNA methylation in luminal differentiation contribute to the aberrant methylation patterns in prostate cancer.

Details

Title
Dynamic patterns of DNA methylation in the normal prostate epithelial differentiation program are targets of aberrant methylation in prostate cancer
Author
Long, Mark D 1 ; Dhiman, Vineet K 2 ; Affronti, Hayley C 2 ; Hu, Qiang 3 ; Liu, Song 3 ; Smiraglia, Dominic J 2 

 Roswell Park Comprehensive Cancer Center, Department of Cancer Genetics and Genomics, Buffalo, USA (GRID:grid.240614.5) (ISNI:0000 0001 2181 8635); Roswell Park Comprehensive Cancer Center, Department of Biostatistics and Bioinformatics, Buffalo, USA (GRID:grid.240614.5) (ISNI:0000 0001 2181 8635) 
 Roswell Park Comprehensive Cancer Center, Department of Cancer Genetics and Genomics, Buffalo, USA (GRID:grid.240614.5) (ISNI:0000 0001 2181 8635) 
 Roswell Park Comprehensive Cancer Center, Department of Biostatistics and Bioinformatics, Buffalo, USA (GRID:grid.240614.5) (ISNI:0000 0001 2181 8635) 
Publication year
2021
Publication date
2021
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2535620952
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.